A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients Whose Disease is Resistant or Refractory to T-DM1, and/or T-DXd, and/or Tucatinib-containing Regimens

  • McCartney, Amelia (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

Effective start/end date8/07/217/08/26


  • phase 2 study
  • breast cancer
  • treatment efficacy
  • treatment safety
  • cancer treatment